NP PHARMA
ActiveFrom the official registers: KBO 1 annual account at the National Bank publications in the Belgian Official Gazette
Summary
NP PHARMA has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €40,694 and a net result of €37,694. Its solvency ranks better than 77% of 22,679 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
History
Acts, filings and financial milestones
2026
04-07
financial year 2025 · micro format
2025
17-02
Gazette deed
IncorporationAppointment: PIZZOFERRATO Nicolas (director) · Founder · Founding capital9 facts ▸
Gazette deed
Incorporation
Appointment: PIZZOFERRATO Nicolas (director) · Founder · Founding capital9 facts ▸
- Incorporation, “NP PHARMA” (deed in French)
- Founder, PIZZOFERRATO Nicolas (comparant requérant)
- Founding capital, €3,000
- Shareholding, 3000
- Other provision, “prise d'effet des dispositions finales et transitoires, comparant” (deed in French)
- Registered office clause, “7030 Saint-Symphorien,résidence du Rieu,8” (deed in French)
- Board rule, 1
- Director appointment, PIZZOFERRATO Nicolas (director (not named in the articles))
- Pre-incorporation commitments, “takeover, tous engagements,obligations et activités entreprises au nom et pour compte de la société en formation” (deed in French)
Gazette deedNBB filing
Sources:Publications in the Belgian Official GazetteFilings with the National Bank